The PI3K pathway analysis revealed that PTEN mutations were more frequent in H/L HCC patients (4.3%) compared to NHW patients (1.5%), though this difference was not statistically significant (p = 0.1202, Table S1). Here, PTEN is linked to hepatocellular carcinoma.